Humacyte, Inc. - *W EXP 08/27/202 (HUMAW)

Q4 2021 13F Portfolio Holders as of 12/31/2021

Type / Class
Equity / *W EXP 08/27/202
Number of holders
17
Total Shares
912K
Shares change
+317K
Total reported value, excl. options
$2.33M
Value change
+$701K
Put/Call ratio
0
Number of buys
6
Number of sells
-4
Price
$2.28
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.